{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:00:01Z","timestamp":1776855601269,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.thromres.2017.05.019","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T13:16:11Z","timestamp":1495631771000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Recurrence of venous thromboembolism among adults acute leukemia patients treated at the University of Texas MD Anderson Cancer Center: Incidence and risk factors"],"prefix":"10.1016","volume":"156","author":[{"given":"Nhiem V.","family":"Luong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Kroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khanh","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.thromres.2017.05.019_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/B:THRO.0000014589.17314.24","article-title":"Cancer and thrombosis: mechanisms and treatment","volume":"16","author":"Deitcher","year":"2003","journal-title":"J. Thromb. Thrombolysis"},{"issue":"6","key":"10.1016\/j.thromres.2017.05.019_bb0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.thromres.2017.05.019_bb0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.019_bb0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"9","key":"10.1016\/j.thromres.2017.05.019_bb0025","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1538-7836.2005.01467.x","article-title":"The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment","volume":"3","author":"De Stefano","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2017.05.019_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2004.07.016","article-title":"Symptomatic venous thromboembolism in acute leukemia: incidence, risk factors, and impact on prognosis","volume":"115","author":"Ziegler","year":"2005","journal-title":"Thromb. Res."},{"issue":"29","key":"10.1016\/j.thromres.2017.05.019_bb0035","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1200\/JCO.2009.22.8197","article-title":"Venous thromboembolism in the hematologic malignancies","volume":"27","author":"Falanga","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.019_bb0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1538-7836.2007.02383.x","article-title":"Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis","volume":"5","author":"Caruso","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"17","key":"10.1016\/j.thromres.2017.05.019_bb0045","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1182\/blood-2008-08-175745","article-title":"Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival","volume":"113","author":"Ku","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2017.05.019_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/cam4.332","article-title":"A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center","volume":"4","author":"Khanh","year":"2015","journal-title":"Cancer Med."},{"issue":"15","key":"10.1016\/j.thromres.2017.05.019_bb0055","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/archinte.165.15.1782","article-title":"Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528, 693 adults","volume":"165","author":"White","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"Suppl. 6","key":"10.1016\/j.thromres.2017.05.019_bb0060","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"issue":"Suppl. 6","key":"10.1016\/j.thromres.2017.05.019_bb0065","doi-asserted-by":"crossref","first-page":"454S","DOI":"10.1378\/chest.08-0658","article-title":"Antithrombotic therapy for venous thromboembolic disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Kearon","year":"2008","journal-title":"Chest"},{"issue":"8791","key":"10.1016\/j.thromres.2017.05.019_bb0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0140-6736(92)91054-C","article-title":"Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis","volume":"339","author":"Prandoni","year":"1992","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.thromres.2017.05.019_bb0075","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJM199005033221802","article-title":"Heparin for 5days as compared with 10days in the initial treatment of proximal venous thrombosis","volume":"322","author":"Hull","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.thromres.2017.05.019_bb0080","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199211193272103","article-title":"Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis","volume":"327","author":"Brandjes","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.thromres.2017.05.019_bb0085","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM199204093261502","article-title":"Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis","volume":"326","author":"Hull","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.019_bb0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0197-2456(00)00104-5","article-title":"Sample-size calculations for the cox proportional hazards regression model with nonbinary covariates","volume":"21","author":"Hsieh","year":"2000","journal-title":"Control. Clin. Trials"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2017.05.019_bb0095","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0049-3848(07)70137-8","article-title":"Bleeding and thrombosis in acute leukemia: what does the future of therapy look like","volume":"120","author":"Rickles","year":"2007","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2017.05.019_bb0100","doi-asserted-by":"crossref","first-page":"V215","DOI":"10.1016\/S0049-3848(01)00285-7","article-title":"Molecular basis for the relationship between thrombosis and cancer","volume":"102","author":"Rickles","year":"2001","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2017.05.019_bb0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2141.2010.08524.x","article-title":"The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on dana-farber cancer institute consortium protocols","volume":"152","author":"Grace","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2017.05.019_bb0110","first-page":"423","article-title":"The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients","volume":"82","author":"Prandoni","year":"1997","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.thromres.2017.05.019_bb0115","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.160.6.769","article-title":"Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors","volume":"160","author":"Hansson","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2017.05.019_bb0120","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archinte.159.5.445","article-title":"Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study","volume":"159","author":"Heit","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2017.05.019_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archinte.1997.00440220061008","article-title":"Upper-extremity deep vein thrombosis: risk factors, diagnosis, and complications","volume":"157","author":"Prandoni","year":"1997","journal-title":"Arch. Intern. Med."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2017.05.019_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000046591","article-title":"Thrombotic complications of central venous catheters in cancer patients","volume":"106","author":"Monreal","year":"2001","journal-title":"Acta Haematol."},{"issue":"8","key":"10.1016\/j.thromres.2017.05.019_bb0135","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1538-7836.2008.03017.x","article-title":"Current perspective of venous thrombosis in the upper extremity","volume":"6","author":"Flinterman","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"19","key":"10.1016\/j.thromres.2017.05.019_bb0140","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2003.08.008","article-title":"Venous thromboembolism associated with long-term use of central venous catheters in cancer patients","volume":"21","author":"Verso","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"8981","key":"10.1016\/j.thromres.2017.05.019_bb0145","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(95)91690-3","article-title":"Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor","volume":"346","author":"Kakkar","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.thromres.2017.05.019_bb0150","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/ATVBAHA.108.162545","article-title":"The epidemiology of venous thromboembolism in the community","volume":"28","author":"Heit","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.thromres.2017.05.019_bb0155","first-page":"267","article-title":"Racial and gender differences in the incidence of recurrent venous thromboembolism","volume":"96","author":"White","year":"2006","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2017.05.019_bb0160","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.jcp.0000088914.24613.51","article-title":"Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study","volume":"23","author":"Wallaschofski","year":"2003","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T09:57:33Z","timestamp":1535795853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384817303377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":32,"alternative-id":["S0049384817303377"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.019","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence of venous thromboembolism among adults acute leukemia patients treated at the University of Texas MD Anderson Cancer Center: Incidence and risk factors","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}